709673452 - Supply of Obiltoxaximab Treatment RFI

A Pre-Procurement Notice
by MINISTRY OF DEFENCE

Source
Contracts Finder
Type
Future Contract ()
Duration
not specified
Value
___
Sector
HEALTH
Published
02 Nov 2023
Delivery
01 Jan 1 to 01 Jan 1
Deadline
24 Nov 2023 23:59

Concepts

Location

Geochart for 1 buyers and 0 suppliers

1 buyer

Description

The Ministry of Defence (MOD) are considering a requirement to procure UK/EU Licensed Obiltoxaximab Treatment as soon as is technically possible. To inform this requirement, the MOD seek information in response to the following: a. Whether it is possible to supply a UK/EU Licensed Obiltoxaximab b. If there is a minimum order quantity c. What price breaks apply, if any. d. Evidence of UK/EU Licensing e. Is this product commercially available off-the-shelf (COTS) f. Indicative pricing g. Lead times In addition to confirming whether the above requirements can be met, the following information is required: 1. Licensing status to include GMP/GDP/GLP/GCP in country of origin and any other licensing restrictions that may apply. The MOD is only seeking information from industry at this stage on availability and basic technical information of potential UK/EU Licensed Obiltoxaximab Treatment that meet or exceed the requirements listed above. Submissions with product data sheets are initially invited. Promising and appropriate responses may be followed up by a meeting to discuss the requirement further. The RFI is without commitment and is subject to contract.

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Other Information

Link to Defence Opportunity https://contracts.mod.uk/esop/guest/go/opportunity/detail?opportunityId=57252

Reference

Domains